Office of The Director, National Institutes of Health; Cancellation of Meeting, 60246 [2020-21118]
Download as PDF
<![CDATA[
60246
Federal Register / Vol. 85, No. 186 / Thursday, September 24, 2020 / Notices
Secretary, to pay Federally Qualified
Health Center and Rural Health Clinic
for the training costs of eligible
physicians and practitioners who obtain
Drug Addiction Treatment Act of 2000
waivers to furnish opioid use disorder
treatment services. This delegation may
not be redelegated and does not confer
authority to issue regulations.
This delegation of authorities is
effective upon date of signature.
Dated: September 18, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2020–21098 Filed 9–23–20; 8:45 am]
BILLING CODE 4150–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of The Director, National
Institutes of Health; Cancellation of
Meeting
Notice is hereby given of the
cancellation of the Office of The
Director, National Institutes of Health,
October 9, 2020, 3:00 p.m. to October 9,
2020, 4:00 p.m., National Institutes of
Health, Building One, One Center Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
August 26, 2020, 85 FR 52614.
This meeting is being cancelled due to
scheduling difficulties and the
presentation will be rescheduled for the
ACD in December 2020.
Dated: September 21, 2020.
Natasha M. Copeland,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21118 Filed 9–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
VerDate Sep<11>2014
17:54 Sep 23, 2020
Jkt 250001
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Novel Synthetic Nucleic Acid
Technology Development SEP.
Date: December 7, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 300, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 300, Bethesda, MD 20892, 301–594–
4280, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 21, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21091 Filed 9–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group; Genome Research Review Committee.
Date: November 5–6, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 300, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
PO 00000
Frm 00122
Fmt 4703
Sfmt 4703
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 300, Bethesda, MD 20892, 301–594–
4280, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 21, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21089 Filed 9–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Biology Structure and Regeneration
Study Section.
Date: October 22–23, 2020.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yanming Bi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–451–
0996, ybi@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Imaging Probes and
Contrast Agents Study Section.
Date: October 22–23, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 85, Number 186 (Thursday, September 24, 2020)]
[Notices]
[Page 60246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of The Director, National Institutes of Health;
Cancellation of Meeting
Notice is hereby given of the cancellation of the Office of The
Director, National Institutes of Health, October 9, 2020, 3:00 p.m. to
October 9, 2020, 4:00 p.m., National Institutes of Health, Building
One, One Center Drive, Bethesda, MD 20892 which was published in the
Federal Register on August 26, 2020, 85 FR 52614.
This meeting is being cancelled due to scheduling difficulties and
the presentation will be rescheduled for the ACD in December 2020.
Dated: September 21, 2020.
Natasha M. Copeland,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-21118 Filed 9-23-20; 8:45 am]
BILLING CODE 4140-01-P
